Histomonosis is a parasitic disease of poultry with worldwide prevalence. The disease can cause morbidity and mortality in chicken and turkey flocks entailing severe economic losses.
Introduction

Emphasis of the review
The focus of the present review is to recapitulate reports investigating different approaches for preventive and therapeutic options against histomonosis since it was first reported (Cushman, 1893) . Additionally, changes in management and husbandry appeared in coincidence with the rise of the poultry industry effecting the epizootiology of the disease are described here. Basic knowledge about the parasite H. meleagridis and the disease histomonosis are mentioned briefly, for a conclusive understanding regarding prevention and therapy of the disease. For broader information on the biology of the parasite and general aspects of histomonosis the authors would like to refer to previously published reviews McDougald, 2005) .
Histomonosis -from emergence to re-emergence
Histomonosis (syn.: blackhead disease or histomoniasis) was primarily observed as infectious enterohepatitis of turkeys (Smith, 1895) . The start of the poultry industry at the end of the 19 th century in the USA was in coherence with the emergence of the disease, causing high losses in turkey farms. Consequently, histomonosis became a severe danger for turkey rearing which was evident by the decline from 6.5 million turkeys in 1900 to 3.6 million birds in 1920 (Animal and Plant Health Inspection Service, 1984) . The need to control the disease at that time and in the following years is reflected by an increase of studies investigating not only the disease and the causative agent H. meleagridis itself, but options for prevention and therapy were within the focus as well. An important finding was the identification of Heterakis gallinarum as a vector for H. meleagridis implicating practical suggestions on the prevention of histomonosis by aspects of biosecurity and worm control (Graybill & Smith, 1920) . Later on, experimental studies demonstrated arsenicals and nitroheterocyclics to be effective against histomonosis (Tyzzer, 1923; Waletzky et al., 1950) . Hence, those drugs became commercially available and by its use outbreaks of the disease in turkeys and chickens could be effectively prevented or treated. However, health concerns were raised on the drugs of both chemical groups on the food safety following administration in food producing animals as recently reviewed (Baynes et al., 2016) . Accordingly, antihistomonal drugs were banned in industrial countries which caused a re-emergence of the parasitic disease in the last years .
Important features of the parasite and its interaction with the host
H. meleagridis belongs to the genus Histomonas, family Dientamoebidae, order Tritrichomonadida. The parasite is unicellular with 3 to 21 µm in size and is composed of an axosytle, a pelta, a costa, parabasal bodies and hydrogensomes, organelles that are commonly found in trichomonads (Hess & McDougald, 2013) . In general, two stages of H. meleagridis can be differentiated: i) the flagellated caecal lumen form and ii) the tissue form without flagella. The caecal lumen form propagates in the caecum and can be observed in liquid cultures following in vitro isolation. The shape is round or amoeboid, tentatively with formation of pseudopodia. The tissue form is located intercellular in organs of the host. Nonflagellated stages can develop an additional membrane when transforming into a more resistant phase. Detailed light and transmission electron microscopy suggested the formation of such cyst-like stages of in vitro cultivated histomonads (Zaragatzki et al., 2010) .
Turkeys suffering from histomonosis show ruffled feathers, drooped wings, apathy and sulphur coloured diarrhoea. The mortality of turkeys can be up to 100% as it was reproduced in various experimental settings, summarized by Hauck and Hafez (2013) . Histomonosis in chickens causes milder clinical signs and a lower mortality, but the disease was reported to be at least as severe as coccidiosis (McDougald, 2005) . The pathogenesis of histomonosis starts with the colonization of the parasite in the caecum leading to severe inflammation and necrosis. Following destruction of intestinal tissue the parasite may infiltrate into blood vessels and reach the liver via the portal veins. As a consequence, areas of inflammation and destruction can occur in the liver. At the final stage, the disease may become systemic when the parasite spreads to various organs of the host . Lesions caused by H. meleagridis are noticed as thickening of the caecal wall, bleedings in the mucosa and fibrinous masses in the lumen of the caecum. Changes in the liver are found as round localized areas of necrosis that can be variable in size. Such lesions can be seen in turkeys and chickens, though they may vary in the severity of pathological changes.
Microscopically, the inflammation is characterized by infiltrations of mixed populations of leukocytes together with areas of necrosis and the presence of tissue stages of H. meleagridis as described above.
Drugs against histomonosis -benefit and limitations
In the past, efforts to prevent or treat the disease focused on the effect of chemical substances. The compounds that were used along with further details on the findings are given in this chapter and key facts on the drugs tested against histomonosis are specified (Table 1) .
Arsenicals. The first compounds which were used efficiently for prevention and treatment of histomonosis were arsenicals. Interference with DNA repair processes and cellular energy metabolisms are mechanisms of these compounds and have a lethal effect on cells (Abernathy et al., 1999; Cobo & Castineira, 1997) . Substances like neoarsphenamine and tryparsamide were found to be potent as therapeutics (Tyzzer, 1923) , whereas other compounds like mapharside and nitarsone were more suitable for prevention by using them as feed additives (Jaquette & Marsden, 1947; Tyzzer, 1923) . Further investigations on nitarsone revealed a clinical relapse after withdrawal of medication (McCulloch & Nicholson, 1941; McGuire & Morehouse, 1952; Morehouse & McGuire, 1950) and continuous use of the drug could affect egg production and growth rates of birds (Moreng & Bryant, 1956 ).
Recently, a reduced sensitivity of H. meleagridis against nitarsone was observed by in vitro assays and following isolation from drug-fed turkeys (Abraham et al., 2014) . The efficacy of the arsenical compound acetarsol against H. meleagridis was not consistently proven based on different experimental settings (Berks & Neal, 1952; Farmer, 1950; Swales, 1952a) .
Nitrofurans. The mode of action of nitrofurans depends on the 5-nitro group of the furan ring.
The substance damages the DNA of microbes by its reduction to multiple reactive intermediates inside the cells by the enzyme nitrofuran reductase (Jin et al., 2011; Zolla & Timperio, 2005) . Different studies demonstrated a preventive effect of nifursol and nifurtimox against histomonosis {Sullivan, 1972 1290 /id; Vatne, 1969 Vatne, 1288 Vatne, 1969 Vatne, 1289 /id;Hauck, 2010 1207 /id}. Therapeutic intervention using furazolidone, another representative of the nitrofurans, was less effective against the disease (Jerstad, 1957; Vatne et al., 1969a; Vatne et al., 1969b) .
Nitroimidazoles. The active part of the nitroimidazoles is the 5-nitro functional group of the imidazole ring which induces damage of the DNA of the parasite (Boechat et al., 2015; Lopez Nigro & Carballo, 2008) . The compounds serve as antibiotics as well as antiprotozoal medications. Especially dimetridazole was for a long time used for therapy of histomonosis because of its good curative efficacy in chickens and turkeys {Flowers, 1965 1274 /id;Morehouse, 1968 1292 /id}. However, other nitroimidazole-compounds like metronidazole, ipronidazole and ornidazole were also found to be effective against histomonosis (Hu & McDougald, 2004; Lindquist, 1962; Mitrovic & Schildknecht, 1970) .
Other studies showed the application of nitroimidazoles as food and/or water additives for prevention as well as treatment (Hu & McDougald, 2004; Lindquist, 1962; Mitrovic & Schildknecht, 1970) .
Benzimidazoles. These bicyclic compounds consist of the fusion of benzene and imidazole.
They interfere with cells of intestinal worms by binding to tubulin proteins causing a damage of the cytoskeleton (Jornet et al., 2016; Lacey & Gill, 1994) . Oral application of albendazole and fenbendazole to turkeys infected with Heterakis gallinarum eggs carrying histomonads had a prophylactic effect (Hegngi et al., 1999) . However, a direct effect of benzimidazoles against H. meleagridis can be excluded based on the results of in vitro studies (Callait et al., 2002; Hauck & Hafez, 2009) . Therefore, it can be concluded that the anthelmintic effect of benzimidazoles reduce the risk to infect poultry with heterakids harboring H. meleagridis.
Nitrothiazoles. Nitrothiazoles are heterocyclic compounds that contain both sulfur and nitrogen. 2-Amino-5-nitrothiazole and 2-acetylamino-5-nitrothioazole were successfully used for prevention and treatment of histomonosis (Brander & Wood, 1955; McGregor, 1952; Swales, 1952b) . Beside the direct impact of the compounds of this group on histomonads, investigations also described an antihelmintic effect of the substance against larvae of H. gallinarum (Swales, 1952b) .
Benzothiazoles. Members of these bicyclic compounds are thiazoles fused with benzene derivatives. Tests of different benzothiazoles like 2-amino-6-nitrobenzothiazole as feed additives showed neither therapeutic nor prophylactic efficacy against histomonosis (Swales, 1952a) .
Nithiazide. Nithiazide is a compound related to 2-amino-5-nitrothiazole. The monosubstituted nitrothiazolyl urea with 1-ethyl was found to be more effective and less toxic than other substituted nitrothiazolyl ureas and enheptin-T when used as feed additive to prevent histomonosis produced either by oral infection of turkeys with H. gallinarum eggs containing histomonads or by cloacal inoculation of an H. meleagridis culture Cuckler et al., 1957) .
Quinolines. 8-Hydroxyquinoline complexes exhibit antiseptic, disinfectant and pesticide properties based on functioning as transcription inhibitor (Cameron et al., 2012; Fraser & Creanor, 1975) . Their prophylactic activity was demonstrated against natural as well as induced infections of turkeys with histomonads (De Volt & Holst, 1948) . In vitro studies demonstrated the inhibition of growth of histomonads by the addition of clioquinol (Berks & Neal, 1952) .
Carbamates. Dithiocarbamates are organic compounds derived from carbamic acid in which both oxygen atoms are replaced by sulfur atoms. Based on the effect of chelating metal ions (e.g. zinc) diethyldithiocarbamates inhibit enzymes like superoxide dismutases and metalloproteinases (Hogarth, 2012) . In vivo tests showed that these substances had potential to treat histomonosis (Swales, 1950) .
Hydrazones, phanquinones and luminal amebicides. Nidrafur was found to have a preventive potential when used as feed additive in the feed of chickens and turkeys Reid et al., 1960) , but therapeutic effects of the same substance and the related compounds entobex and furamide were not observed Hu & McDougald, 2004) .
Antibiotics. In the past, antibiotics that were initially used against bacterial infections were also investigated for their antihistomonal effect. In this context it should be mentioned that paromomycin sulfate was tested effectively against protozoan parasites, like Entamoeba histolytica and other intestinal protozoa (Carter et al., 1962) . Paromomycin has an antimicrobial effect by inhibiting the protein synthesis of target organisms (Eustice & Wilhelm, 1984; Mehta & Champney, 2003) . Lindquist (1962) found that the drug was effective to prevent histomonosis but application after infection of turkeys did not reduce the number of losses. Later on, further in vivo studies confirmed these outcomes and also in vitro experiments showed a reduction of cultivated histomonads (Bleyen et al., 2009a; Hafez et al., 2010; Hu & McDougald, 2004; van der Heijden et al., 2011) . Furthermore, tiamulin, a pleuromutilin antibiotic was reported to be effective in a field observation (Burch et al., 2007) and investigated for an anti-histomonads effect by in vitro assays (Hauck et al., 2010b; van der Heijden et al., 2011) . However, the results of the last mentioned studies where not consistent arguing for further investigations using in vivo experiments. Carbadox, which leads to intercalation and inclusion of mutations in the DNA of susceptible bacteria (Chen et al., 2008) , was shown to reduce the growth of histomonads in vitro, but a reduction of liver and caecal lesions could not be observed in turkeys (Hu & McDougald, 2004) . However, as the propagation of H. meleagridis strongly depends on the presence of bacteria (Bradley & Reid, 1966 ) it needs to be clarified whether an inhibitory effect directly targeted the protozoan or only the bacteria and indirectly histomonads.
Legislation on the use of drugs against histomonosis
The application of drugs for food producing animals is in many countries regulated by national authorities in order to exclude or minimize side effects and to ensure consumer (CEC, 1996) . These regulations implicate that food being imported fulfils the same specifications as domestic products. In the USA the application of nitroheterocyclic compounds in food producing animals is also not allowed (FDA, 2015a) and just recently the approval for the use of the arsenical nitarsone in animal feed has been withdrawn (FDA, 2015b) . Similar regulations that resulted in the loss of any preventive or therapeutic options against histomonosis were applied in other countries, like Japan, Canada, Australia and New Zealand that are directly or indirectly involved in the International
Cooperation on Harmonisation of Technical Requirements for the Registration of Veterinary
Medicinal Products (VICH). Furthermore, it was elsewhere described that many other OECD countries have no approval for nitroimidazoles in food producing animals (Baynes et al., 2016) . Despite this, the application of drugs against histomonosis is still permitted in most other countries. However, South Africa, China, Brazil, Argentina, Russia, India, the West African Economic and Monetary Union, the Veterinary Medicines Committee of the Americas and others attended one of the VICH Global Outreach Forums for the purpose of raising awareness of VICH guidelines among non-VICH countries (Smith, 2013) . This indicates that laws, regulations, guidance and policies relevant to the control of veterinary medicines are of increasing relevance and therefore ban of antihistomonal drugs in food producing animals may be implemented in future in additional countries. As a consequence of this, it can be hypothesized that the re-emergence of histomonosis may extend to a severe problem in different countries. The following case histories should exemplarily demonstrate the impact of histomonosis in different farms and restricted veterinary interventions according to European legislation.
Actual cases of histomonosis with restricted veterinary medical care
In an event of recent outbreaks of histomonosis in turkey flocks in Austria, measures had to be taken to prevent prolonged suffering of the birds or, if possible, the fatal outcome. In total, 10 outbreaks of histomonosis affecting 7 different farms of commercial turkeys with mostly severe consequences have been recorded in a period from July 2014 until September 2015, of which 3 cases are briefly described below.
Case 1: Commercial turkeys were reared in 3 neighbouring houses owned by two different farmers located in an area of a few hundred square meters. The first outbreak occurred in the middle house populated with male turkeys at the age of 8 weeks and 5000 of 7200 birds died within 9 days after the first appearance of clinical signs before the remaining birds were slaughtered. Four months later, birds in the neighboring house belonging to the second farmer became affected. At this time, the house contained 2700 male and the same number of female turkeys separated by a simple wire fence. At the age of 5 weeks, typical clinical signs were noticed in male turkeys before a high number of them died. In order to avoid suffering of the remaining toms and to reduce the shedding of the parasite, all male turkeys were culled. However, one week later, also the hens had to be killed after they started to contract histomonosis. The third outbreak occurred in the so far unaffected third house containing different compartments with 3200 toms and 5000 hens at the age of 7 weeks, just one month after the second outbreak. This time all turkeys from this house were immediately slaughtered to prevent the rapid spread of the disease within the flock.
Following the first outbreak in the series of three, enhanced biosecurity measures were applied after depopulation, including sweeping and washing with water and detergents, formalin gassing, iodine based disinfection in doubled concentrations along with insecticides and anticoccidial agents in the houses, silos, litter storages together with spreading of lime around the premises. Additionally, the herbal products Protophyt ® (Phytosynthese, Mozac, France) and/or Sangrovit ® (Phytobiotics, Eltville, Germany) were applied in the feed.
In a subsequent incidence of histomonosis in the middle house, 10 months after the last outbreak on this farm, 7500 female turkeys were affected at their 5 th week of life. This time paromomycin sulfate (Parofor ® , Huvepharma, Sofia, Bulgaria) was administered via drinking water in a dosage of 12.5 mg/kg bodyweight for 10 days immediately after the birds showed clinical signs of histomonosis. Following treatment, only marginal losses due to histomonosis of overall 8 birds were observed until the flock was slaughtered at the age of 16 weeks.
Case 2: The flock consisted of 11500 turkey hens that showed adverse clinical signs and an increased mortality at week 7 of life. After histomonosis was confirmed by pathology and direct detection of the parasite, paromomycin sulfate (Parofor ® ) was applied at week 9 of life with the same dose as mentioned above. However, the administration of the drug was stopped after 5 days of usage, because the daily mortality could not be reduced. Overall, 42% of the birds died until the end of production 6 weeks later and 254 carcasses had to be condemned during slaughter.
Case 3: Histomonosis occurred in a house with 5100 male and 6900 female turkeys separated by a wire fence. Mortalities already started at 21 days of age in female turkeys after which they were culled. Thereafter, the male birds started to show clinical signs and paromomycin sulfate (Parofor ® ; 12.5 mg/kg bodyweight) was administered via the drinking water on the next day. The mortality was moderate in the first 4 days of treatment before a sudden increase in mortalities was noted and the birds had to be culled.
The short summary of field outbreaks of histomonosis given above did not provide encouraging results in regard to the taken actions to control histomonosis with currently available options. The importance of hygiene and biosecurity to prevent histomonosis are described specifically below, but as exemplified in the mentioned cases it was not sufficient to prevent histomonosis. Paromomycin sulfate is allowed for "off-label" use in turkeys in Europe against histomonosis after the disease is diagnosed. This restriction in application of the drug can be explained by the development of resistant enteric bacteria in turkeys following administration as continuous feed supplementation (Kempf et al., 2013) . However, as the drug has only a prophylactic and not a therapeutic effect, this procedure offers a certain dilemma. In any case, timely diagnosis and application is crucial to induce a metaphylactic effect against histomonosis.
Alternative and recent approaches to control the disease
Hygiene and biosecurity
The introduction of H. meleagridis into a poultry flock determines the outbreak of the disease therefore, it is essential to reduce the risk of an initial infection of birds by measures of biosecurity. Since the parasite effectively multiplies in infected birds, the transmission within a flock can occur rapidly as it was experimentally demonstrated Landman et al., 2015; McDougald & Fuller, 2005) . The knowledge how histomonads can be introduced into a flock is highly relevant. The unsheltered parasite has a low tenacity and the survival time outside the hosts is relatively short. However, the parasite was shown to survive in contaminated water or faecal material for up to 9 hours (Lotfi et al., 2012) , a time period in which transmission can occur also between houses or farms by indirect transmission. The most effective way to transmit the parasite is via the intermediate host H. gallinarum which can harbour H. meleagridis (Graybill & Smith, 1920) . Eggs of the caecal worm are highly resistant against environmental impacts and can be infective for several years. Furthermore, earthworms are vectors for H. gallinarum and are accordingly a potential source to spread H. meleagridis (Lund et al., 1966b) which underlines the requirement for a proper biosecurity.
Additionally, preventive measures against the incidence of H. gallinarum include the accurate control of the worm. Regular parasitic examinations are important to immediately start with deworming procedures in order to minimize H. gallinarum. Between bird replacements cleaning and disinfection with substances effective against worm eggs are indicated. Disinfectants containing peracetic acid fulfil this requirement (van der Gulden & van Erp, 1972) . All sources infected or contaminated with H. gallinarum must be kept away from poultry. This includes other birds, for instance pheasants that are known to transmit both parasites (Lund & Chute, 1972) . Furthermore, insects, rodents and other vermin that can be considered to act as mechanical transport hosts must be strictly controlled. Litter contaminated with H. meleagridis and H. gallinarum was shown to induce the disease and therefore all the equipment and clothes that come in contact with it are potential vectors. The detection of histomonad-DNA in dust samples by PCR was shown to be highly suitable for investigating the prevalence of the parasite in a poultry flock (Grafl et al., 2015) . However, dust does not seem to be a potential source of infection because PCR-positive dust did not contain microscopically detectable cells of H. meleagridis and was not infective for turkeys in a preliminary experimental setting (Liebhart et al., 2013b) .
Anyhow, the effect of biosecurity to prevent the introduction of histomonads depends on the housing system and is very much limited in free-range flocks or in houses that cannot be fully closed. This is consistent with the finding that the seroprevalence of H. meleagridis is higher in pullets and layers kept in free-range systems compared to chickens that are housed on deep litter (Grafl et al., 2011) . Although biosecurity is important to reduce the risk of an outbreak in a chicken or turkey flock, it is not always possible to prevent the infection with H. meleagridis as described in the chapter above and as reported previously from breeder flocks of turkeys and chickens, where a high level of biosecurity can be assumed (Callait-Cardinal et al., 2007; Dolka et al., 2015) . Birds kept free range are more likely exposed to parasites, although there are certain factors that influence the occurrence or severity of histomonosis. In a recent study, significant relationships of flock management and histomonosis were found (Callait-Cardinal et al., 2010) . Most important, it was reported that mortality tended to be high when low hygiene and acidification of the drinking water were practised. However, more data are needed to identify possible entrance routes of the parasite into a flock and general measures to prevent or limit the infection.
Plant-derived compounds
Several compounds from plants were tested for their effect against H. meleagridis applying in vitro and/or in vivo experiments (Table 2) . Relevant parameters for in vitro studies were the growth rate, respectively the inhibition of multiplication of the parasite. The impact of the used substances was often defined as minimum lethal concentration (MIC). For infection trials mostly turkeys were used to investigate clinical parameters and pathological changes in order to conclude a possible antihistomonal effect. In the following subchapters the different plant derived compounds are categorized according to the type of extract or the chemical classes and the most relevant findings are briefly summarized.
Plant-derived essential oils. Essential oils obtained from different plants such as cinnamon,
lemon, rosemary, garlic and thyme were tested for their potential as medication against histomonosis. The oils were able to suppress the growth of the parasites when added to in vitro cultures of histomonads (Grabensteiner et al., 2007; Hauck & Hafez, 2007; van der Heijden & Landman, 2008a; Zenner et al., 2003) . The commercial product Protophyt® (Phytosynthese) includes the essential oils of cinnamon, garlic, rosemary, lemon and was previously surveyed for its antihistomonal effect in different studies (Hafez & Hauck, 2006; van der Heijden & Landman, 2008b) . However, the results were very contradictory ranging from a certain prophylactic activity to no efficacy.
Ethanol and water extracts. Tests of ethanol and water extracts derived from the different plants like Thymus vulgaris, Vitis vinifera, Olea europaea, Peganum harmala, Ginkgo biloba
and Aesculus hippocastanum showed an influence on the growth behavior of histomonads in in vitro cultures, whereas extracts used as water additive for experimentally infected turkeys with H. meleagridis did not have any appreciable efficacy regarding prevention of histomonosis Grabensteiner et al., 2008) .
Further extracts and lyophilisates. The product Natustat™ which contains unspecified plant extracts was described to have an effect against histomonosis in turkeys and chickens kept on infected litter (Duffy et al., 2004; Duffy et al., 2005) . However, investigations on this plant derived feed additive using a well-defined infection model are not available. Other Alkaloids and sesquiterpene lactons. In vitro investigations using the β-carboline alkaloids harmane, harmalol, harmaline and harmine as well as the steroidal glycoalkaloid saponin derived from the plant Quillaja saponaria demonstrated the effectiveness of these substances on the growth rate of histomonads Grabensteiner et al., 2007) . In the same way, the sesquiterpene lacton artemisinin and material of Artemisia annua, as well as extracts derived from this plant, showed potential to suppress growth of histomonads in culture (Thofner et al., 2012) . On the other hand, the addition of artemisinin and a dichloromethane Artemisia annua extract to feed or water, respectively, was not suitable to prevent chickens or turkeys from histomonosis (Thofner et al., 2012) .
Vaccination
Investigations on vaccination against histomonosis include several studies, starting already at the beginning of last century with experiments that assessed differences in the virulence of H. meleagridis until the recent establishment of a well-defined experimental vaccination model for turkeys and chickens (Table 3) . During the first attempts to isolate H. meleagridis in vitro followed by in vivo application, it was found that the parasite lost its virulence by longterm cultivation (Tyzzer, 1934) . In a subsequent manuscript Tyzzer (1936) summarized all of his immunization experiments describing a certain protective effect of in vitro attenuated histomonads in chickens and turkeys, but found no uniformity of attenuation in regard to the duration of cultivation between different isolates. He also observed in this study that immunising properties decreased during extended time of cultivation in vitro and pathogenicity of attenuated histomonads could not be restored by serial passages in chickens or turkeys. Nevertheless, the investigations at that time did not result in the development of an efficient vaccine.
Later on, Lund (1959; showed that virulent histomonads did not cause the disease when the birds were initially inoculated with a non-pathogenic strain specified as Histomonas wenrichi. In further experiments, the same author and colleagues (Lund et al., 1966a) observed immunizing properties of H. meleagridis following in vitro cultivation but they hypothesized that the loss of virulence during cultivation was due to a selection process between different virulent strains of the parasite present in the material used for cultivation.
This hypotheses was later on disproven by establishing of in vitro attenuated clonal H. meleagridis combining micromanipulation with long term passaging (up to 295x) . However, prolonged in vitro attenuation of more than 1000 passages was shown to obliterate the immunogenicity of H. meleagridis (Lund et al., 1967) .
Around mid of the last century chemotherapy was proven to be effective against histomonosis as described above. At that time it was also found that birds which recovered from an infection by antihistomonal treatment can develop resistance against histomonosis, supporting the idea of vaccination (Brackett & Bliznick, 1949; Kendall, 1957; Sautter & Pomeroy, 1950) . Although Clarkson (1963) confirmed this result he demonstrated that precipitating antibodies did not protect naive turkeys against a severe challenge. He concluded that a protective immunity against histomonosis must be produced by a serum factor, leukocytes or by local immunity of the caecal mucosa. In agreement with his observations Hess et al. (2008) and Bleyen et al. (2009b) were unable to protect turkeys with inactivated histomonads. In contrast to this, we could achieve full protection from fatal histomonosis by vaccination using a well-defined clonal culture of in vitro attenuated histomonads in turkeys . In continuation, the successful oral administration of attenuated histomonads to day-old turkeys was demonstrated successfully for the first time (Liebhart et al., 2010) . The established vaccine candidate was further investigated for its safety with the outcome that i) no clinical signs or pathological lesions were found in chickens and turkeys that were vaccinated and ii) the strain used for vaccination did not revert to virulence following consecutive passages in both host species and only minimal lesions were noticed (Sulejmanovic et al., 2013) . In another study, the vaccine was applied as monoxenic inoculum which had no effect on the attenuation and efficacy (Ganas et al., 2012) . Further experiments in adult layers have shown that vaccinated birds can be protected from a severe drop in egg production caused by histomonosis (Liebhart et al., 2013a) . Most recently, cross-protection by the mentioned attenuated clonal strain against genetically different isolates of H. meleagridis was demonstrated in turkeys (Sulejmanovic et al., 2016) .
Finally, Nguyen et al. (2013) reported the implementation of serial in vivo passages in turkeys to obtain a low virulent isolate which protected turkeys from a severe challenge, supporting the concept of a live vaccine.
Outlook on the control of histomonosis
Requirements of new approaches
This review summarized studies on drugs, plant derived compounds or vaccination that were performed in order to elucidate options for prevention or treatment of histomonosis. The urgent need for effective prophylaxis and therapy is evident since several countries banned effective and widely used drugs due to safety concerns. Consequently, new substances as alternatives to be used against the disease have to fulfil comprehensive regulations when used in food producing animals as outlined above. The main requirement of chemical agents or its derivates applied against histomonosis are, beside a significant effect against the parasite, the safety of the product. Most important are criteria regulating the prevention of residues or at least the compliance of maximum residue limits in eggs or meat of poultry.
Furthermore, it should also be excluded that a certain drug induces resistant microorganisms, either the parasite itself or the microbiota in general. Standards and recommendations are given by the Codex Alimentarius. Considering the high demand to fulfil all regulations for a substance to be used in food producing animals it seems very unlikely that such a drug will enter the market in the near future.
Botanicals may be applied as feed additive and therefore the application is specifically regulated by law, exemplarily given from the EU (EC, 2003). As mentioned above, several plant substances were tested for their effect to prevent histomonosis without substantial impact on the progression and outcome of the disease. It needs to be determined in controlled experiments whether new plant derived substances have an antihistomonal effect.
For instance, approaches to alleviate coccidiosis in poultry with different botanicals was recently summarized (Bozkurt et al., 2013) . Anyhow, the characteristics of the parasite H. meleagridis and the pathogenicity of histomonosis requires proper investigations to confirm an antihistomonal effect and well defined in vitro and in vivo assays are essential for this. In vitro studies are a pre-requisite in assessing a potential effect against H. meleagridis and are needed to minimize animal experiments. However, it should be pointed out that in vivo experiments are mandatory to confirm an impact against the disease considering that different recent investigations noticed severe differences between in vitro and in vivo studies (Table 2) .
As already pointed out, vaccination based upon an attenuated clonal strain of H. meleagridis was shown to be highly effective and a live vaccine seems at present the most suitable tool to successfully prevent the disease. However, further efforts are needed to standardize the production and to optimize the administration of the vaccine in the field. It remains questionable whether the introduction of advanced molecular and genomic techniques which were just recently applied to study H. meleagridis will lead to new achievements with regard to vaccine development.
In any case a better understanding of the host-parasite interaction is needed in order to elucidate the mechanisms of protection. In a recent study it was shown that that chickens raised an earlier immune response than turkeys in the caeca based on cytokine expression profiles, which could possibly explain the milder course of the disease in chickens (Powell et al., 2009) . Considering the severe impact on the gut epithelium a comparison with Eimeria spp. seems very obvious although both parasites display a very different biology. Similarities in the immune reactions against coccidia and H. meleagridis include the severe inflammation and destruction of intestinal host tissue and the accumulation of cytokines (Powell et al., 2009; Rose, 1996) . However, the most relevant distinction is the intracellular presence of Eimeria spp. compared to the intercellular infiltration of H. meleagridis in tissues. This should fundamentally affect the immune cascade during infection. For Eimeria spp. it is known that activation and involvement of T cells occurs and they are essential to establish an immunity against a re-infection (Smith et al., 2014) . It is well known that the mammalian immune system can be divided into the type 1 and type 2 pathways, depending on the causative pathogen. Birds show a similar range of immune response, as reported by Degen et al. (2005) who demonstrated Th1/Th2 polarization by intracellular (viral) and extracellular (helminth) infection in chickens. However, an experimental helminth infection model is not very reliable because of the different development stages of the nematode (egg -larvaeadult worm). H. meleagridis, an extracellular protozoan parasite that propagates only by binary cell division should be a good candidate to elucidate the development of the type 2 pathway in chickens, the focus of an ongoing project at our clinic.
Conclusion
Histomonosis is a re-emerging disease in various countries without permission to use effective chemotherapeutics. Different strategies to prevent the disease including the use of chemicals, plant-derived compounds or vaccination were comprehensively investigated in the last years. Chemotherapeutics against histomonosis are not licensed anymore and compounds from plants did not show promising effects in vivo. Vaccination using in vitro attenuated H. meleagridis effectively protects chickens and turkeys from histomonosis and is safe in use, arguing for the most promising approach for future prevention of histomonosis in poultry. Blount, 1938; Farmer, 1950; Sautter & Pomeroy, 1950; Swales, 1950 mapharside (mapharsen) n.i. prophylactic nontherapeutic intramuscular application Blount, 1938; Jaquette & Marsden, 1947; McCulloch & Nicholson, 1941 nitarsone (4-nitro-phenyl-arsonic acid) n.i. prophylactic feed and water Duffy et al., 2004; McGuire & Morehouse, 1952 carbarsone (p-ureidobenzenearsonic acid) n.i. prophylactic feed Bowen et al., 1971; Welter & Clark, 1961; Whitmore et al., 1968 roxarsone (3-nitro-phenyl arsonic acid) yes no feed Callait et al., 2002; Hu & McDougald, 2002 sodium acetarsol no prophylactic feed and water Berks & Neal, 1952; Farmer, 1950; Sautter et al., 1952; Swales, 1952a nitrofuran damage of DNA furazolidone yes therapeutic feed Costello, 1956; Horton-Smith & Long, 1957; Jerstad, 1957; Jowett, 1911; McGregor, 1953; Vatne et al., 1969b Flowers et al., 1965; Hu & McDougald, 2004; McGuire et al., 1964; Morehouse et al., 1968 metronidazole (1-(2'-hydroxyethyl)-2-methyl-5-nitroimidazole) yes prophylactic & therapeutic water Hegngi et al., 1999; Hu & McDougald, 2004; Lindquist, 1962 ipronidazole n.i. prophylactic & therapeutic feed Mitrovic et al., 1968; Mitrovic & Schildknecht, 1970 ronidazole (1-methyl-2-carbamoyloxymethyl-5-nitroimidazole) n.i. prophylactic water Peterson, 1968; Shelton & McDougle, 1970; Sullivan et al., 1977; Whitmore et al., 1968 ornidazole yes therapeutic feed Hu & McDougald, 2004 tinidazole yes therapeutic feed benzimidazole binding on betatubulin, damage of cytoskeleton, interference of spindly apparatus, inhibition of cell division albendazole no prophylactic direct oral application Callait et al., 2002; Hauck & Hafez, 2009; Hegngi et al., 1999; Hu & McDougald, 2004 fenbendazole no prophylactic direct oral application Callait et al., 2002; Hauck & Hafez, 2009; Hegngi et al., 1999 Berks & Neal, 1952; Cooper & Skulski, 1957; Grumbles et al., 1952; Horton-Smith & Long, 1957; McGregor, 1952; Pino et al., 1955; Swales, 1950; Swales, 1952b; Waletzky et al., 1950 entramin A (2-acetylamino-5-nitrothiazole)
n.i. prophylactic & therapeutic feed Brander & Wood, 1955; Grumbles et al., 1952; Price & Gingher, 1955 benzothiazole inhibition of catalases and peroxidases p-(6-nitro-2-benzothiazolylamino) benzoic acid n.i. nontherapeutic feed Swales, 1952a 2-amino-6-nitrobenzothiazole n.i. nontherapeutic yes prophylactic feed Berks & Neal, 1952; De Volt & Holst, 1948; Farmer, 1950; Wedgeforth & Wedgeforth, 1921 5-chloro-8-hydroxyquinoline n. 
